XPENG Launches G9 Flagship SUV
21.9.2022 15:00:00 EEST | Business Wire | Press release
XPeng Inc. (XPENG or the Company, NYSE: XPEV and HKEX: 9868), today reveals the pricing and specifications for its 4th production model G9 Flagship SUV for the Chinese market. The G9 lineup includes three series - each with a different driving range - and six configurations in total.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220921005601/en/
XPENG Reveals Price Details of G9 (Photo: Business Wire)
There will be three series of G9—each with a different driving range—and six configurations in total. These are the RWD 570G, RWD 570E, and RWD 702E; 4WD Performance 650E and 650X; and a Launch Edition 650X. The 4WD Performance models come with a dual-chamber air suspension system as standard. G9 will start from 309,900 up to 469,900 RMB with the first deliveries for customers in China expected in October.
"G9 is the world's fastest-charging mass-production SUV and boasts the industry's first full-scenario Advanced Driver Assistance System. This is topped off with a dual-chamber air suspension system and a luxurious smart cabin that includes a groundbreaking 5D music experience we call Xopera. G9 is a fusion of many technical innovations woven together into an elegant design and marks a significant milestone after eight years of dedication.
We believe it will become the new benchmark for smart EVs, representing the last step before the realization of truly autonomous vehicles," said He Xiaopeng, CEO and Chairman of XPENG, during G9's online launch event.
G9 launch event broadcast
English: https://heyxpeng.com/events/01834992d10982358a5f2c9e246a024a
Chinese: https://www.xiaopeng.com/g9.html
The World’s Fastest-Charging Electric SUV
XPENG G9 boasts a new powertrain system using China’s first 800 V mass-production Silicon Carbide (SiC) platform. Supported by the Company's new 480 kW S4 supercharging stations, the 4C version of G9 can add up to 200 km of CLTC range in as little as five minutes—this means it can charge from 10–80% in only 15 minutes. The standard 3C version can charge from 10–80% in 20 minutes, which is also superior to most fast-charging EVs in the industry. Even when charging with compatible third-party stations, G9 demonstrates far greater charging efficiency compared to other EVs built on a 400 V platform.
In addition to significantly improving charging speeds, XPENG is rapidly expanding its nationwide charging network. In August, the Company unveiled its 1,000th charging location and its new S4 supercharging technology along with plans to add over 500 S4 supercharging locations across major cities nationwide in 2023; By 2025, XPENG aims to open up a total of 2,000 supercharging locations across China.
G9 offers a maximum CLTC range of 702 km, leading the mid-size SUV class. The other two versions of G9 offer up to 570 km and 650 km (4WD) of CLTC range—between 460 and 570 km when converted to WLTP range, which easily covers most urban commutes.
G9 also uses drag-reducing styling, a high-voltage SiC powertrain with advanced power distribution, and an energy recovery system to minimize wasted power while maximizing the driving range. This means G9's real-world usable range is 5–10% higher than mainstream EVs.
XNGP, the Second-Generation ADAS With Full-Scenario Assistance
G9 uses XPENG's second-generation Advanced Driver Assistance System, XNGP, featuring industry-first full-scenario driver assistance.
The X Version of G9 makes use of dual NVIDIA DRIVE Orin chips which deliver 508 TOPS (trillion operations per second) of computing performance. G9 uses 31 sensors and a front-view camera for advanced object detection—its front-mounting dual-LiDAR sensors cover 180º, reducing the size of blind spots.
XNGP is capable of tackling multiple driving scenarios, regardless of the high-precision map’s coverage—by 2023 when it is available in most cities in China.
XPENG's first-generation ADAS, XPILOT, comes standard on the E version of G9. Technological advancements and algorithmic iterations coupled with higher computing power elevate the performance of XPILOT’s existing ADAS functions that include ACC, LCC, VPA (Valet Parking Assist), and Highway NGP (Navigation Guided Pilot).
With the new hardware and software architecture driven by closed-loop data, XPENG developed an enhanced Advanced Emergency Braking (AEB) active safety function on the E and X versions of G9.
Four-Zone Always-on Voice Assistant and 3D UI Represent New Benchmarks
G9 redefines driver-vehicle interaction with a new voice assistance system. Powered by MIMO (Multiple Input Multiple Output) technology, the new voice assistant in G9 can respond to commands from all four areas of the cabin, even understanding successive instructions from different passengers without needing to be constantly reactivated. With its upgraded computing power, G9's always-on voice assistant responds in milliseconds and can even control over 600 vehicle functions without the need for a network connection.
G9 debuts XPENG's interactive 3D user interface based on the Unity3D engine, offering drivers a seamless and interactive experience. The 3D map accurately renders the vehicle's surrounding in real-time onto a high-definition 14.96" dual screen for precise feedback during driving.
Powerful Performance
The total power of G9's dual motors in the 4WD versions can reach 405 kW (551 hp), with a maximum torque of 717 Nm, helping it accelerate from 0–100 km/h in 3.9 seconds. The SUV also has powerful braking capabilities and can come to a complete stop from 100 km/h in just 34.6 meters. G9 has seven driving modes, including a Boost Mode that helps the vehicle reach its maximum torque in 0.15 seconds.
G9 adopts an advanced double-wishbone suspension at the front and five-link suspension at the rear as well as a double-chamber air suspension system with 100 mm of range. This provides a wider range of stiffness adjustments that, in combination with XPENG's ADAS, help G9 handle complex road conditions with ease.
All in the Details
G9 has a rear trunk volume of 660 L that increases to 1,576 L when the rear seats are folded, so large objects such as golf bags can be easily accommodated. The front and back seats can be folded and adjusted to create a more relaxing and luxurious space. G9 is also equipped with a deployable electric tow bar and a 220 V outlet with up to 2200 W of power, giving owners more options on their journeys.
The Xopera 5D Multimedia Experience
To create the ultimate audio-visual entertainment experience, XPENG has introduced Xopera to G9. Xopera is XPENG's proprietary multimedia system, engineered to create a unique and immersive in-cabin experience. The system boasts concert hall-level acoustic engineering by utilizing an 18-speaker Dynaudio Confidence system with a total of 28 speakers and vibration units that produce a total output of 2250 W.
Using Dolby Atmos technology, Xopera provides passengers with an immersive 5D experience that includes seat vibrations, changes to the ambient lighting, adjustable air conditioning, and customized fragrances when watching a film, listening to music, or simply relaxing.
A New Standard for Global Markets
G9 has been designed for both the Chinese and international markets from the start. The SUV is purposefully designed with an international perspective to meet the C-NCAP and E-NCAP five-star safety standards, as well as the stringent EU WVTA vehicle certification standards.
XPENG G9 visual assets: XPENG_G9_visual_assets_for_media
XPENG G9 Specs:
|
Version |
RWD Standard |
RWD Long
|
4WD Performance |
||||
|
570G |
570E |
702E |
650E
|
650X
|
650X Launch
|
||
|
Dimensions |
|
|
|
|
|
|
|
|
Length/Width/Height |
4891 mm/1937 mm/1680 mm |
4891 mm/1937 mm/1670 mm |
|||||
|
Wheelbase |
2998 mm |
||||||
|
Number of Seats |
5 seats |
||||||
|
Trunk Space/ Trunk Space (Rear seats down) |
660 L/1,576 L |
||||||
|
Drivetrain |
Single-motor Rear-wheel Drive |
Double-motor Four-wheel Drive |
|||||
|
Power Output (kW)/ Torque (Nm) |
Rear 230 kW / 430 N•m |
Front 175 kW / 287 N•m, Rear 230 kW / 430 N•m |
|||||
|
CLTC Driving Range |
570 km |
570 km |
702 km |
650 km |
650 km |
650 km |
|
|
Maximum Speed |
200 km/h |
||||||
|
Acceleration (0-100 km/h) |
6.4 s |
3.9 s |
|||||
|
|
|
|
|
|
|
|
|
Follow us:
XPENG Twitter
XPENG LinkedIn
XPENG Facebook
About XPeng Inc.
XPeng is a leading Chinese Smart EV company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to drive Smart EV transformation with technology and data, shaping the mobility experience of the future. In order to optimize its customers’ mobility experience, XPeng develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture. XPeng is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Silicon Valley, San Diego and Amsterdam. The Company’s Smart EVs are mainly manufactured at its plant in Zhaoqing, Guangdong province. For more information, please visit https://heyxpeng.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about XPeng’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: XPeng’s goals and strategies; XPeng’s expansion plans; XPeng’s future business development, financial condition and results of operations; the trends in, and size of, China’s EV market; XPeng’s expectations regarding demand for, and market acceptance of, its products and services; XPeng’s expectations regarding its relationships with customers, contract manufacturers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in XPeng’s filings with the SEC. All information provided in this press release is as of the date of this press release, and XPeng does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005601/en/
Contact information
For Investor Enquiries:
IR Department
XPeng Inc.
Email: ir@xiaopeng.com
Jenny Cai
The Piacente Group
Tel: +1 212 481 2050 / +86 10 6508 0677
Email: xpeng@tpg-ir.com
For Media Enquiries:
PR Department
XPeng Inc.
Email: pr@xiaopeng.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
